Cargando…
Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4(+) T cells in melanomas
METHODS: In this study, we developed a strategy for the prevention and therapy of melanoma using a whole-cell vaccine combined with a CpG/αOX40/cGAMP triple adjuvant. The CpG/αOX40/cGAMP triple adjuvant was used to co-culture melanoma cells in vitro to induce immunogenic death of tumor cells. The mi...
Autores principales: | Du, Xuedan, Wu, Jinting, Zhao, Ye, Wang, Bin, Ding, Xiaobo, Lin, Qiuyan, Chen, Yingyu, Zhao, Jinduo, Liu, Lixiao, Mao, Xiaolu, Fang, Zhen, Zhang, Chunhong, Li, Wenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587117/ https://www.ncbi.nlm.nih.gov/pubmed/35748951 http://dx.doi.org/10.1007/s00432-022-04117-8 |
Ejemplares similares
-
Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy
por: Cai, Luya, et al.
Publicado: (2021) -
cGAMP the travelling messenger
por: Blest, Henry T. W., et al.
Publicado: (2023) -
Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
por: He, Yanpu, et al.
Publicado: (2020) -
The Signaling Pathway That cGAMP Riboswitches Found: Analysis and Application of Riboswitches to Study cGAMP Signaling in Geobacter sulfurreducens
por: Tan, Zhesen, et al.
Publicado: (2022) -
Human SLC46A2 Is the Dominant cGAMP Importer in Extracellular
cGAMP-Sensing Macrophages and Monocytes
por: Cordova, Anthony F., et al.
Publicado: (2021)